PEOPLE - Orthofix makes appointment:
This article was originally published in Clinica
Orthofix has appointed Oliver Burchkardt as president of its international division. He joins the firm from Pennsylvania-based Aesculap (surgical instruments), where he was vice-president of spine sales and marketing. During his eight years there, he: established a US business unit for spine products, and led the international product management team and the global product portfolio for the spine division.
You may also be interested in...
OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.